System Distinguishes Protein Expression Patterns from Two Prostate Cancer Types
Study data demonstrate the ability of the Adapt system to differentiate exosomes from cancer cell subtypes from the same tumor type.
Read More
Search Results for: prostate cancer
Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read MoreMyriad: NCCN Updates Professional Guidelines for Patients with Prostate Cancer
The Prolaris test from Myriad Genetics was one of only two prognostic tests for prostate cancer recommended by NCCN for the new expanded indications.
Read MoremiR Scientific Introduces Sentinel Disease Management Platform
The Sentinel disease management platform incorporates a number of noninvasive liquid biopsy urine tests that can help accurately detect, score, and monitor urological cancers.
Read More
AI System Can Detect and Grade Prostate Cancer
The AI system has the potential to solve one of the bottlenecks in today’s prostate cancer histopathology by providing more accurate diagnosis and better treatment decisions.
Read More